carbapenems has been researched along with bli-489 in 2 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (bli-489) | Trials (bli-489) | Recent Studies (post-2010) (bli-489) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 6 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chikala, R; Ratnakar, KS; Sritharan, V; Swathi, CH | 1 |
| Liu, Q; Shi, S; Xu, M; Yao, Z; Ye, J; Zhang, X; Zhang, Y; Zhou, B; Zhou, C; Zhou, T | 1 |
1 review(s) available for carbapenems and bli-489
| Article | Year |
|---|---|
A structural, epidemiological & genetic overview of
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Phylogeny | 2016 |
1 other study(ies) available for carbapenems and bli-489
| Article | Year |
|---|---|
Synergistic effect of the novel β-lactamase inhibitor BLI-489 combined with imipenem or meropenem against diverse carbapenemase-producing carbapenem-resistant Enterobacterales.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Escherichia coli; Imipenem; Klebsiella pneumoniae; Lactams; Meropenem; Microbial Sensitivity Tests; Monobactams | 2022 |